Lithuanian-founded Spike secures €3.2M to help health enterprises with GenAI technology
Summary
Silicon Valley-headquartered and Lithuanian-founded Spike, a B2B data technology and AI startup, announced on Tuesday that it has raised $3.5M (approximately €3.2M) in an oversubscribed seed round. However, the integration of these technologies often faces significant challenges, including strict regulatory compliance for sensitive health data, LLM hallucinations, intense competition for AI engineering talent, lengthy development timelines, and high costs. Spike provides non-diagnostic and easy-to-implement RAG AI (Retrieval Augmented Generation) products for health professionals and end users through its white-labeled SDKs. Povilas Gudzius, Spike CEO and Co-founder, comments, “Advancements in retrieval-augmented generation AI mean that LLMs are no longer taking a ‘best guess,’ but are now able to seek out specialised context producing outputs that are much more accurate and considerably less prone to hallucinations. As the influx of sensor data changes some parts of the health industry, Spike is well-positioned for significant growth, and we are excited to partner with such a forward-thinking team.
Funding
Classifications
AskAI Classifications
LabelsLinked Companies
